Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Adopting more stringent guidelines in the UK could reduce food-related greenhouse gas emissions by 70% and reduce diet-related deaths by more than 100,000 a year

Selection of foods layed out on a dark surface

Researchers led by Dr Marco Springmann from the Nuffield Department of Population Health, have found that most dietary recommendations provided by national governments are not compatible with global environmental and health targets such as the Paris Climate Agreement and the Sustainable Development Goals. Recommending stricter limits on meat and dairy, and encouraging increased consumption of whole grains, fruits and vegetables, legumes, and nuts would be both healthier and lower in environmental impacts, their study found.

A team at the LEAP (Livestock, Environment and People) programme at the University of Oxford, and at Harvard, Tufts and Adelaide universities, looked at dietary recommendations from 85 countries. The paper, published today in The BMJ, is the first of its kind to analyse both the health and environmental outcomes of national dietary guidelines around the world.

The researchers modelled the adoption of guidelines at both the national and global level, and compared the impacts to global environmental and health targets that governments have agreed to and that are related to diets. These include, for example, the goal to reduce premature mortality from non-communicable diseases by a third, and the agreement to limit global warming to below 2 degrees Celsius.

The full story is available on the Nuffield Department of Population Health website

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.